FDA Inspection 1244909 — E+ Oncologics Louisiana, L.L.C.
The FDA completed an inspection of E+ Oncologics Louisiana, L.L.C. on Jul 9, 2024 in Opelousas, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 9, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Opelousas, LA (United States)